13 million Afghans at risk of
contracting Leishmaniasis, says WHO
Source: Government of the Islamic Republic of
Afghanistan; World Health Organization (WHO)
October 14, 2010
Kabul, Afghanistan – The World Health Organization
(WHO) today launched its first global report on
neglected tropical diseases. In light of an ongoing
Leishmaniasis outbreak in Herat, Afghanistan, WHO
along with the Ministry of Public Health and the
Afghan Red Crescent Society used this opportunity to
raise awareness about and advocate for neglected
diseases in Afghanistan, with special emphasis on
Leishmaniasis, a disease that threatens the health of
13 million vulnerable Afghans, especially women and
girls.
In Kabul, commonly considered as the world capital
of [Cutaneous] Leishmaniasis, the number of new
reported cases dramatically rose from the estimated
yearly figure of 17,000 to 65,000 in 2009, mainly
among women and girls.
"This number is likely to be the tip of the iceberg
as cases are grossly underreported owing to poor
diagnostic tools and the stigma that is attached to
this disease," claimed Peter Graaff, WHO
Representative to Afghanistan.
[Cutaneous] Leishmanisis is a parasitic disease
transmitted through the bite of certain species of
sandfly. The major symptom is skin sores which erupt
weeks to months after the person has been bitten.
Leishmaniasis is both preventable and curable.
Preventable through bed nets, and curable through
medical treatment.
"The high cost of treatment makes it difficult to
integrate anti-Leishmaniasis drugs into the Basic
Package of Health Services," said Her Excellency Dr
Suraya Dalil, Acting Minister of Public Health. "I
urge donors to take this cause seriously, as it causes
unnecessary suffering amongst a large number of
Afghans."
"Addressing stigma, early diagnosis and early
treatment is the way to go about tackling this
disease," said Fatima Gilani, Director of the Afghan
Red Crescent Society. "Protecting people from
Leishmaniasis is affording them the Right to Life with
dignity." |